Zedan, A. H., Osther, P. J. S., Assenholt, J., Madsen, J. S., & Hansen, T. F. (2020). Circulating miR-141 and miR-375 are associated with treatment outcome in metastatic castration resistant prostate cancer. Sci Rep.
Stile di citazione ChicagoZedan, A. H., P. J. S. Osther, J. Assenholt, J. S. Madsen, e T. F. Hansen. "Circulating MiR-141 and MiR-375 Are Associated With Treatment Outcome in Metastatic Castration Resistant Prostate Cancer." Sci Rep 2020.
Citazione MLAZedan, A. H., et al. "Circulating MiR-141 and MiR-375 Are Associated With Treatment Outcome in Metastatic Castration Resistant Prostate Cancer." Sci Rep 2020.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.